• CMA levies fines of £2.3m in pharma probe pharmatimes
    July 10, 2020
    The UK's Competition and Markets Authority (CMA) has now formally concluded that three pharmaceutical companies - Aspen, Tiofarma, and Amilco - took part in an illegal arrangement that inflated the price of life-saving medicine fludrocortisone.
  • UK CMA disqualifies pharma company director after breaking competition law europeanpharmaceuticalreview
    June 16, 2020
    A pharmaceutical company director is now banned from holding a director role at any UK company for the next five years after making illegal arrangements.
PharmaSources Customer Service